Cargando…

Finally sofosbuvir: an oral anti-HCV drug with wide performance capability

Chronic Hepatitis C virus (HCV) infection is the leading cause of advanced liver disease worldwide. The virus successfully evades host immune detection and for many years has hampered efforts to find a safe, uncomplicated, and reliable oral antiviral therapy. Initially, interferon and ribavirin ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Kayali, Zeid, Schmidt, Warren N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4270038/
https://www.ncbi.nlm.nih.gov/pubmed/25540594
http://dx.doi.org/10.2147/PGPM.S52629